mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.15 |
0.004 |